FDA Eases Rules for Cancer Tests to Speed Patient Access
Published Date: 6/11/2025
Proposed Rule
Summary
The FDA is changing the rules for certain cancer test kits called in situ hybridization (ISH) systems, making them easier to get approved by moving them from a strict category (class III) to a less strict one (class II). This means companies can bring these tests to market faster, but they still have to meet safety and quality checks. This update helps patients get important cancer treatments sooner without extra costs or delays.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
ISH Cancer Tests Reclassified to Class II
The FDA proposes to reclassify in situ hybridization (ISH) test systems indicated for use with a corresponding approved oncology therapeutic product (product codes NYQ, MVD, OWE, and PNK) from class III (premarket approval) to class II (special controls). These devices would become subject to premarket notification instead of premarket approval, which the agency says enables companies to bring the tests to market faster and may speed patient access to the corresponding oncology treatments.
New Special Controls and Premarket Rules
FDA is proposing a new device classification regulation that sets out the special controls manufacturers must meet to provide a reasonable assurance of safety and effectiveness for these ISH test systems. Manufacturers would need to meet those special controls while using the class II pathway and premarket notification process.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-16714, Agency Information Collection Activities; Proposed Collection; Comment Request; Third Party Disclosure and Recordkeeping Requirements for Reportable Food
The Food and Drug Administration (FDA or the Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the information collection provisions of FDA's third-party disclosure and recordkeeping requirements for reportable food.
2026-16712, Agency Information Collection Activities; Proposed Collection; Comment Request; Imports and Electronic Import Entries
The FDA wants your thoughts on how they collect info about imports and electronic import entries. If you’re involved in importing goods, this could affect you! They’re asking for comments by October 16, 2026, to help improve the process without adding extra costs or hassle.
2026-16715, Agency Information Collection Activities; Proposed Collection; Comment Request; Investigational New Drug Application Requirements
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Previous / Next Documents
Previous: 2025-10548, Air Plan Approval; West Virginia; 2024 Amendments to West Virginia's Ambient Air Quality Standards
The EPA is giving a thumbs-up to West Virginia’s updated air quality rules for 2024. This means the state will use the latest national air standards and monitoring methods to keep the air cleaner and safer. People and businesses in West Virginia should get ready for these changes, which help protect health without adding extra costs right now.
Next: 2025-10477, Lower 37 GHz Band and Use of Spectrum Bands Above 24 GHz for Mobile Radio Service
The FCC wants to tighten rules for using super high-frequency airwaves above 37 GHz to keep things running smoothly and avoid interference. They’re asking for ideas on improving how companies share this space and exploring smarter, faster ways to manage it. This affects mobile service providers and could shape how new tech rolls out, with some rule fixes coming soon.